Compare TFIN & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TFIN | PAHC |
|---|---|---|
| Founded | 1981 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | 2014 |
| Metric | TFIN | PAHC |
|---|---|---|
| Price | $61.62 | $51.93 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $63.00 | $34.33 |
| AVG Volume (30 Days) | 259.9K | ★ 297.5K |
| Earning Date | 01-26-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | 72.22 | ★ 373.98 |
| EPS | 0.93 | ★ 2.26 |
| Revenue | $435,852,000.00 | ★ $1,464,325,000.00 |
| Revenue This Year | $7.27 | $15.34 |
| Revenue Next Year | $11.31 | $3.28 |
| P/E Ratio | $66.41 | ★ $23.12 |
| Revenue Growth | 9.98 | ★ 32.39 |
| 52 Week Low | $42.90 | $16.16 |
| 52 Week High | $77.84 | $56.30 |
| Indicator | TFIN | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 43.55 | 72.46 |
| Support Level | $59.45 | $50.94 |
| Resistance Level | $70.66 | $52.89 |
| Average True Range (ATR) | 3.97 | 2.26 |
| MACD | -0.46 | 1.03 |
| Stochastic Oscillator | 19.79 | 77.19 |
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.